143 related articles for article (PubMed ID: 31786577)
1. Developmental Differences in Platelet Inhibition Response to Prostaglandin E1.
Palma-Barqueros V; Torregrosa JM; Caparrós-Pérez E; Mota-Pérez N; Bohdan N; Llanos MDC; Begonja AJ; Sola-Visner M; Vicente V; Teruel-Montoya R; Rivera J; Ferrer-Marín F
Neonatology; 2020; 117(1):15-23. PubMed ID: 31786577
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
3. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
Fisch A; Michael-Hepp J; Meyer J; Darius H
Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
[TBL] [Abstract][Full Text] [Related]
4. Platelet prostaglandin E1 hyposensitivity in schizophrenia: reduction of prostaglandin E1- or forskolin-stimulated cyclic AMP response in platelets.
Ofuji M; Kaiya H; Nozaki M; Tsurumi K
Life Sci; 1989; 45(22):2135-40. PubMed ID: 2557518
[TBL] [Abstract][Full Text] [Related]
5. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
Williams KA; Murphy W; Haslam RJ
Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
[TBL] [Abstract][Full Text] [Related]
6. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP
J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
[TBL] [Abstract][Full Text] [Related]
7. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
[TBL] [Abstract][Full Text] [Related]
8. Migraine: possible role of platelet insensitivity to prostaglandin E1 (PGE1).
Cerneca F; de Luyk S; Radillo O; Simeone R; Mangiarotti M
Funct Neurol; 1993; 8(6):403-8. PubMed ID: 8150318
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
10. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
Zahavi M; Zahavi J; Kakkar VV
Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
[TBL] [Abstract][Full Text] [Related]
11. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
Eigenthaler M; Nolte C; Halbrügge M; Walter U
Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
[TBL] [Abstract][Full Text] [Related]
12. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
[TBL] [Abstract][Full Text] [Related]
13. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1.
Gachet C; Cazenave JP; Ohlmann P; Bouloux C; Defreyn G; Driot F; Maffrand JP
Biochem Pharmacol; 1990 Dec; 40(12):2683-7. PubMed ID: 2175608
[TBL] [Abstract][Full Text] [Related]
14. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood.
Kikura M; Kazama T; Ikeda T; Sato S
Platelets; 2000 Dec; 11(8):446-58. PubMed ID: 11177444
[TBL] [Abstract][Full Text] [Related]
15. Role of cyclic nucleotides in rapid platelet adhesion to collagen.
Polanowska-Grabowska R; Gear AR
Blood; 1994 May; 83(9):2508-15. PubMed ID: 7513202
[TBL] [Abstract][Full Text] [Related]
16. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
[TBL] [Abstract][Full Text] [Related]
17. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
Jaschonek K; Renn W; Weisenberger H
Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
[TBL] [Abstract][Full Text] [Related]
18. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.
Hall DA; Hourani SM
Biochem Pharmacol; 1994 Mar; 47(6):1013-8. PubMed ID: 8147900
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
Khanna V; Armstrong PC; Warner TD; Curzen N
Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
[TBL] [Abstract][Full Text] [Related]
20. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets.
Zahavi M; Zahavi J; Kakkar VV
Life Sci; 1984 Oct; 35(14):1497-503. PubMed ID: 6090838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
